GLUE
Monte Rosa Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$16.02
-0.02 ▼ -0.12%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$16.02
+0.00 +0.00%
| Index | RUT | P/E | 52.46 | EPS (ttm) | 0.31 | Insider Own | 38.92% | Shs Outstand | 0.06B | Perf Week | -10% |
| Market Cap | 1.22B | Forward P/E | - | EPS next Y | -479.8% | Insider Trans | -0.18% | Shs Float | 0.05B | Perf Month | -15.51% |
| Enterprise Value | 0.87B | PEG | - | EPS next Q | -0.35 | Inst Own | 61.37% | Short Float | 21.72% | Perf Quarter | -7.02% |
| Income | 0.02B | P/S | 6.73 | EPS this Y | 73.68% | Inst Trans | 0.82% | Short Ratio | 6.16 | Perf Half Y | 227.61% |
| Sales | 0.18B | P/B | 4.03 | EPS next 5Y | -18.34% | ROA | 5.41% | Short Interest | 10.12M | Perf YTD | 2.17% |
| Book/sh | 3.98 | P/C | 3.12 | EPS past 3/5Y | 14.78% -41.09% | ROE | 9.28% | 52W High | -37.83% ($25.77) | Perf Year | 157.97% |
| Cash/sh | 5.13 | P/FCF | 8.42 | Sales past 3/5Y | - | ROIC | 7.43% | 52W Low | 357.7% ($3.50) | Perf 3Y | 169.24% |
| Dividend Est. | - | EV/EBITDA | 51.68 | EPS Y/Y TTM | 116.97% | Gross Margin | 95.41% | Volatility(W/M) | 6.75% 6.55% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 4.79 | Sales Y/Y TTM | 1112.27% | Oper. Margin | 4.69% | ATR (14) | 1.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.54 | EPS Q/Q | -12.99% | Profit Margin | 11.54% | RSI (14) | 32.95 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.54 | Sales Q/Q | 38.54% | SMA20 | -11.16% ($18.03) | Beta | 1.66 | Target Price | $33.17 |
| Payout | - | Debt/Eq | 0.16 | Earnings | 11000000 | SMA50 | -19.41% ($19.88) | Rel Volume | 0.51 | Prev Close | $16.04 |
| Employees | 134 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 9.91% 73.85% | SMA200 | 40.11% ($11.43) | Avg Volume(3M) | 1.64M | Price | $16.02 |
| IPO | 2021/6/24 | Option/Short | Yes/Yes | Trades | 11420 | Volume | 834,061 | Change | -0.12% |
뉴스 로딩 중...